BioScience Ventures Inc. Overview

*****

BioScience Ventures, Inc. is a San Diego-based biopharmaceutical consulting firm founded in 1991 specializing in:

(1) Global Strategic Alliances in Japan, North America & Europe

(2) Worldwide Business Development / Corporate Development

(3) Deal structures & terms, and

(4) M&A advisory.


David Palella, the Founder/President and sole principal, has extensive business expertise in the areas of:

(1) Oncology / Cancer
(2) Therapeutic monoclonal antibodies & proteins
(3) Autoimmune, inflammatory & infectious diseases
(4) Specialty pharmaceuticals
(5) Biomarkers / personalized medicine
(6) Stem cells & regenerative medicine
(7) Biofuels, bioplastics, green chemistry & pathway engineering
(8) Cleantech, alternative energy, carbon offsets & carbon trading

David is also a private investor and holds stock positions, warrants or options in several private American biotech companies.

Past and current clients of BioScience Ventures include ICOS Corp.; Takeda Chemical Industries; Biosite; Diversa; Maxygen; Prometheus Laboratories; Myriad Genetics; Chiome Biosciences; Karo Bio AB; BioPredict; Novacta Biosystems; Chenomx; Astute Medical; Avid Bioservices; Genetics Squared; SangStat; EPIcyte; Structural Bioinformatics; CombiChem; Eisai Co.; Hisamitsu; Mitsubishi Chemical; Nippon Kayaku; Sumitomo Chemical; and Teijin.

David has initiated and facilitated the closing of dozens of in- and out-licensing deals for his clients ranging in size from US$ 15 – 25 million all the way down to no-cash technology barter deals.

David has spoken at biotech conferences around the world on competitive and technology trends in the therapeutic antibody/protein, oncology and specialty pharma areas, including in Greece, Cyprus, Australia, Germany, Japan, China and at many events in the U.S. He was the originator of and regularly chaired SRI’s Antibody Dealmaking & Finance Conference during 2002-2005, and he also co-chaired SRI’s Antibody World Summit conference. David is frequently an invited panel moderator or panelist and noted for his outside-the-box thinking and penetratingly frank opinions.

He has been an active and continuous member of Licensing Executives Society (LES) since 1992. David’s up-to-date Rolodex stretching back 15 years comprises over 20,000 people.

In 2005 David organized the first meeting of the San Diego Persian Biotech group, which immediately became organized as the non-profit Iranian-American Life Science Networking group (IALSN).

Outside the biotech realm, David is the inventor of the cell phone-based Carbon Micro-Credit and its application in the Developing World to monetize the carbon offsets of poor families who reduce their carbon footprints by means of solar cooking or other behavioral changes. He is also co-founder of Dekadrakma ™ Investments, an investment advisory firm, and originator of the Dekadrakma™ Index of hard asset-based stocks.

David spent too much time in university and has an MBA, B.S. and B.A. (summa cum laude, Phi Beta Kappa & Phi Kappa Phi -- for what that's worth) from Arizona State University and an M.S. in Japanese Business Studies (MSJBS) from Chaminade University in Honolulu, Hawaii.


Contact information:

David Palella
President
BIOSCIENCE VENTURES, INC.

3830 Valley Centre Drive
PMB #581 / Suite 705
San Diego, CA 92130-3307

tel: 858-793-0741
email: dpalella@san.rr.com

http://community.keithferrazzi.com/profile/DavidPalella

For your handy reference, a typical Google search:

http://www.google.com/search?hl=en&q=%22bioscience+ventures%22+david+palella&btnG=Search

-------------------

Other links for David Palella:

--> http://www.carbonmanna.org

http://www.marketwire.com/press-release/Carbon-Manna-Unlimited-991442.html

http://www.marketwire.com/press-release/Carbon-Manna-Unlimited-953397.html

--> http://carbonmanna.blogspot.com

--> http://dekadrakma.blogspot.com


*****